# FDA 483 - Lovelace Biomedical Research Institute - January 27, 2026

Source: https://www.keypedia.com/records/483/lovelace-biomedical-research-institute/06275513-06c6-4093-ab6e-d49bde789606

> FDA 483 for Lovelace Biomedical Research Institute on January 27, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Lovelace Biomedical Research Institute
- Inspection Date: 2026-01-27
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West IV
- Summary: An FDA inspection of Lovelace Biomedical Research Institute in Albuquerque, NM, a GLP Laboratory Facility, revealed two significant issues. The facility failed to retain all raw data generated from nonclinical laboratory studies and did not assure that challenge agents were appropriately tested for identity. These observations indicate deficiencies in data integrity and quality control practices.

## Related Documents

- [483 - 2016-11-11](https://www.keypedia.com/records/483/lovelace-biomedical-research-institute/eafa7733-bf35-47e1-ba77-643c55059848)
- [483 - 2019-09-13](https://www.keypedia.com/records/483/lovelace-biomedical-research-institute/2cc69e59-a746-45c0-8ae0-e016b5b84b9e)
- [EIR - 2019-09-13](https://www.keypedia.com/records/eir/lovelace-biomedical-research-institute/5b2bd139-86c9-4bdd-af30-792f94524848)
- [483 - 2025-04-18](https://www.keypedia.com/records/483/lovelace-biomedical-research-institute/37b00ecb-4653-4dfa-8787-6f44185c7385)

## Related Officers

- [Theressa B. Smith](https://www.keypedia.com/people/theressa-b-smith/80f0c339-7eac-4c73-b9f6-ecb368738fe6)
- [Jonathan R. Campos](https://www.keypedia.com/people/jonathan-r-campos/f4c6aba7-d0fe-43d2-95ae-5eb86a6659a4)

Company: https://www.keypedia.com/companies/lovelace-biomedical-research-institute/3d1ce1c8-86cd-403c-b468-d2b26ef4c77c

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iv/683a371a-36d2-4745-90d9-200f1efd4090